Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Yusta

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Annual Review of Physiology|October 29, 2013
Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2Daniel J Drucker, Bernardo Yusta
Gastroenterology|March 16, 2010
ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowelJasmine Bahrami, Bernardo Yusta, Daniel J Drucker
The Journal of Biological Chemistry|April 30, 2002
Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinaseBernardo Yusta, Jennifer Estall, Daniel J Drucker
Molecular Biology of the Cell|June 1, 2004
Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitizationJennifer L Estall, Bernardo Yusta, Daniel J Drucker
Endocrinology|April 27, 2012
Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in miceBernardo Yusta, Dianne Holland, James A Waschek, et al.
The Journal of Biological Chemistry|April 9, 2005
The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activationJennifer L Estall, Jacqueline A Koehler, Bernardo Yusta, et al.
Molecular and Cellular Endocrinology|April 6, 2004
IGF-I signaling prevents dehydroepiandrosterone (DHEA)-induced apoptosis in hypothalamic neuronsShuo-Yen J Lin, Hong Cui, Bernardo Yusta, et al.
Cancer Research|October 3, 2008
Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cellsJacqueline A Koehler, Will Harper, Maja Barnard, et al.
The Journal of Biological Chemistry|November 1, 2002
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosisYazhou Li, Tanya Hansotia, Bernardo Yusta, et al.
Endocrinology|June 26, 2019
Localization of Glucagon-Like Peptide-2 Receptor Expression in the MouseBernardo Yusta, Dianne Matthews, Jacqueline A Koehler, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Annual Review of Physiology|October 29, 2013
Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2Daniel J Drucker, Bernardo Yusta
Gastroenterology|March 16, 2010
ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowelJasmine Bahrami, Bernardo Yusta, Daniel J Drucker
The Journal of Biological Chemistry|April 30, 2002
Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinaseBernardo Yusta, Jennifer Estall, Daniel J Drucker
Molecular Biology of the Cell|June 1, 2004
Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitizationJennifer L Estall, Bernardo Yusta, Daniel J Drucker
Endocrinology|April 27, 2012
Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in miceBernardo Yusta, Dianne Holland, James A Waschek, et al.
The Journal of Biological Chemistry|April 9, 2005
The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activationJennifer L Estall, Jacqueline A Koehler, Bernardo Yusta, et al.
Molecular and Cellular Endocrinology|April 6, 2004
IGF-I signaling prevents dehydroepiandrosterone (DHEA)-induced apoptosis in hypothalamic neuronsShuo-Yen J Lin, Hong Cui, Bernardo Yusta, et al.
Cancer Research|October 3, 2008
Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cellsJacqueline A Koehler, Will Harper, Maja Barnard, et al.
The Journal of Biological Chemistry|November 1, 2002
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosisYazhou Li, Tanya Hansotia, Bernardo Yusta, et al.
Endocrinology|June 26, 2019
Localization of Glucagon-Like Peptide-2 Receptor Expression in the MouseBernardo Yusta, Dianne Matthews, Jacqueline A Koehler, et al.
Pageof 4